June 9 Web Event: Americans’ Knowledge and Attitudes About Abortion Access and the Pending Supreme Court Ruling June 9, 2022 Event On June 9, KFF released findings from a national public opinion survey on abortion. The event highlighted key issues including awareness and attitudes of the impending Supreme Court opinion, its potential impact on abortion access, the importance of abortion policy to voting preferences in this year’s midterm elections, and knowledge of abortion and related health care.
16 States and DC Have State Laws Protecting the Right to Abortion if Roe v. Wade is Overturned June 17, 2022 Slide If the Supreme Court overturns Roe v. Wade, states will set their own abortion policies without any federal constitutional standards. Access to abortion care will be protected in 16 states and DC, while abortion will likely become illegal for 18 states.
Many States Impose a Jail Sentence for Doctors Who Perform Abortions Past Gestational Limits May 23, 2022 Slide Many states impose a jail sentence for doctors who perform abortions past state established gestational limit. Here’s the breakdown of the jail time and state established gestational limits in effect as of May 2022.
Challenges to the FDA’s Approval of Medication Abortion Pills Could Curtail Access Throughout the United States March 14, 2023 News Release In anticipation of a ruling in a case with enormous implications for access to medication abortion in the United States, a new KFF brief explains the impact of this case, and others filed in federal courts, involving the FDA’s regulation of medication abortion. The case that has gotten the most…
Medication Abortion in the Courts: What’s at Stake? March 8, 2023 News Release Access to medication abortion has emerged as a central issue following the Dobbs decision overturning Roe v. Wade. There is ongoing litigation in four federal cases about the FDA’s approval and regulation of mifepristone, one of the two drugs used in medication abortion. Mifepristone, approved by the FDA in 2000,…
New KFF Trackers Document State and Federal Reproductive Rights Litigation Across the Country February 23, 2023 News Release KFF has created two new trackers to follow swift-moving reproductive rights litigation in the state and federal courts. The tools, which are currently tracking the status of 21 state cases in 15 states and eight federal cases, will be updated regularly as the litigation proceeds. Major cases pending in federal…
The Public, Including Women of Childbearing Age, Are Largely Confused About the Legality of Medication Abortion and Emergency Contraceptives in Their States February 1, 2023 News Release More than six months since the Supreme Court issued their Dobbs decision which overturned Roe v. Wade, there is widespread public confusion about the medication abortion pill and whether it is legal at the state level, according to the latest KFF Health Tracking Poll. The poll also finds many are…
KFF Health Tracking Poll: Early 2023 Update On Public Awareness On Abortion and Emergency Contraception February 1, 2023 Poll Finding Following the FDA approval of retail pharmacies carrying and distributing medication abortion, this poll finds that the public’s awareness and knowledge of emergency contraception and medication abortion is still lacking, especially among respondents living in states with full abortion bans.
Dec. 13 Web Event: What is the future of contraceptive care in a post-Roe world? December 13, 2022 Event The Supreme Court’s decision to overturn Roe v. Wade and subsequent state abortion bans have moved the issue of access to high-quality and affordable contraceptive care to the forefront. As these seismic shifts shape women’s health care in the United States, the FDA is considering an application for a daily…
Abortion Bans May Limit Access to Certain Drugs Used to Treat Women with Cancer, Autoimmune Diseases, and Ulcers November 17, 2022 News Release A new KFF analysis finds that women comprise the majority of patients who rely on certain drugs that may be restricted in response to state abortion bans. Following the Supreme Court decision to overturn Roe v. Wade, some women in abortion-banning states have reported that clinicians and pharmacists denied them…